Description

DUPHALAC SYRUP 450ML

Indications

DUPHALAC SYRUP 450ML is primarily indicated for the treatment of constipation. It is also used to manage hepatic encephalopathy, a condition that arises from liver failure leading to the accumulation of toxins in the bloodstream. The syrup is effective in softening stools, making them easier to pass, and it helps to regulate bowel movements.

Mechanism of Action

The active ingredient in DUPHALAC SYRUP is lactulose, a synthetic disaccharide. Once ingested, lactulose is not absorbed in the gastrointestinal tract but is metabolized by colonic bacteria into short-chain fatty acids. This process creates an osmotic effect, drawing water into the colon and increasing the water content of the stool. As a result, the stool becomes softer and easier to pass. Additionally, in the case of hepatic encephalopathy, lactulose helps to reduce the absorption of ammonia in the intestines, thereby lowering blood ammonia levels.

Pharmacological Properties

DUPHALAC exhibits osmotic laxative properties, which are beneficial in treating constipation. The syrup is non-toxic and does not cause dependency, making it a preferred choice for long-term use in managing chronic constipation. The pharmacokinetics of lactulose indicate that it is poorly absorbed, and its effects are localized primarily in the colon. The onset of action typically occurs within 24 to 48 hours after administration, making it a reliable option for patients seeking relief from constipation.

Contraindications

DUPHALAC SYRUP should not be used in patients with known hypersensitivity to lactulose or any of the other ingredients in the formulation. It is also contraindicated in individuals with galactosemia, a rare genetic disorder that affects the metabolism of galactose. Furthermore, patients with intestinal obstruction or perforation should avoid using this product, as it may exacerbate these conditions.

Side Effects

While DUPHALAC is generally well-tolerated, some patients may experience side effects. Common side effects include abdominal discomfort, bloating, flatulence, and diarrhea. These symptoms are typically mild and transient. In rare cases, excessive use of lactulose may lead to electrolyte imbalances or dehydration. It is important for patients to adhere to the recommended dosage to minimize the risk of adverse effects.

Dosage and Administration

The recommended dosage of DUPHALAC SYRUP varies depending on the indication. For the treatment of constipation, adults typically start with a dose of 15 to 45 mL per day, which may be adjusted based on individual response. For children, the dose is usually lower and should be determined by a healthcare professional. In the management of hepatic encephalopathy, the initial dose may be higher, often starting at 30 to 50 mL taken three times daily, with subsequent adjustments made based on the patient’s ammonia levels and clinical response. It is advisable to take the syrup with water or juice to enhance palatability.

Interactions

DUPHALAC SYRUP may interact with certain medications, particularly those that affect electrolyte balance or gastrointestinal motility. For instance, diuretics may increase the risk of electrolyte imbalances when used concurrently with lactulose. Additionally, the laxative effect of DUPHALAC may alter the absorption of other oral medications, potentially reducing their efficacy. Patients should inform their healthcare providers of all medications they are taking to ensure safe and effective use of DUPHALAC.

Precautions

Before using DUPHALAC SYRUP, patients should consult their healthcare provider, especially if they have a history of gastrointestinal disorders, diabetes, or renal impairment. Caution is advised in elderly patients or those with comorbid conditions that may increase the risk of dehydration. It is essential to monitor bowel habits and ensure adequate fluid intake while using this product to prevent complications associated with laxative use.

Clinical Studies

Clinical studies have demonstrated the efficacy of lactulose in treating constipation and hepatic encephalopathy. A randomized controlled trial published in a peer-reviewed journal showed that patients receiving lactulose experienced significant improvements in stool frequency and consistency compared to those receiving placebo. Another study highlighted the role of lactulose in reducing blood ammonia levels in patients with hepatic encephalopathy, leading to improved cognitive function and quality of life. These findings support the clinical use of DUPHALAC as a safe and effective treatment option.

Conclusion

DUPHALAC SYRUP 450ML is a well-established osmotic laxative that provides effective relief from constipation and aids in the management of hepatic encephalopathy. Its unique mechanism of action, combined with its favorable safety profile, makes it a valuable option for patients seeking a reliable solution for bowel regulation. As with any medication, it is important for patients to use DUPHALAC responsibly and under the guidance of a healthcare professional to ensure optimal outcomes.